Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2015-03-13 Proxy Solicitation & In…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于召开2015年第一次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice about convening the 2015 first extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bio-pharmaceutical Co., Ltd. It details the meeting date, voting methods (onsite and online), eligibility, agenda items, and voting procedures. It does not contain any financial statements or results, nor is it a transcript or report of the meeting outcomes. The document is a formal announcement to shareholders about the upcoming meeting and how to participate and vote. It fits the definition of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings. The document length is 4165 characters, which is consistent with a detailed meeting notice rather than a full report or results announcement.
2015-03-13 Chinese
关于重大事项停牌的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from Jiangsu Sihuan Bio Co., Ltd. regarding the suspension of trading of its stock due to the planning of a major matter with uncertainty. It references the stock suspension starting from March 6, 2015, and states that the company will disclose further information as required. There is no financial data, no report attached or published, and the document is very brief (453 characters). This fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about trading suspension and not a financial report or detailed disclosure.
2015-03-06 Chinese
关于召开2015年第一次临时股东大会通知
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a notice about convening the 2015 first extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bio-pharmaceutical Co., Ltd. It details the meeting date, voting methods (onsite and online), eligibility, agenda items, registration methods, and voting procedures. There is no financial data or report content, only procedural and logistical information about the shareholder meeting. The document is under 5,000 characters and serves as a formal announcement to shareholders about the meeting and voting process. This fits the definition of a Proxy Solicitation & Information Statement (PSI), which provides information to shareholders to request votes for meetings.
2015-03-04 Chinese
独立董事意见
Board/Management Information Classification · 90% confidence The document is a formal opinion from independent directors regarding a loan renewal for a subsidiary, referencing regulatory guidelines and company bylaws. It does not contain financial statements, earnings data, or detailed financial analysis. It is a standalone opinion related to governance and compliance matters, not a full report or announcement of voting results. The document length is short (402 characters), and it is a formal statement by independent directors, which fits best under Board/Management Information (MANG) as it relates to management oversight and governance.
2015-03-04 Chinese
第七届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It details decisions made at the seventh board's ninth meeting, including approval of a loan extension and the proposal to convene an extraordinary shareholders' meeting. The document is short (1034 characters) and primarily announces board decisions rather than providing detailed financial data or full reports. It does not contain financial statements or comprehensive management discussion. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2015-03-04 Chinese
关于全资子公司对外委托贷款公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a loan transaction by a wholly-owned subsidiary of the company. It details the terms of the entrusted loan, the parties involved, financial data of the borrower and guarantor, and the approval process including board and shareholder meeting requirements. The document does not contain comprehensive financial statements or detailed financial performance data of the company itself. It is a specific announcement about a financing activity (entrusted loan) and its renewal, rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is relatively short (2316 characters), but it contains substantive information about the financing transaction, not just a notice of report publication or certification. Hence, it is not RPA or RNS.
2015-03-04 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.